IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 187 filers reported holding IMMUNOGEN INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $72,000 | +80.0% | 11,117 | -0.3% | 0.00% | – |
| Q3 2020 | $40,000 | -23.1% | 11,146 | -0.5% | 0.00% | – |
| Q2 2020 | $52,000 | -32.5% | 11,199 | -26.2% | 0.00% | – |
| Q4 2019 | $77,000 | +120.0% | 15,169 | +5.3% | 0.00% | – |
| Q3 2019 | $35,000 | -59.8% | 14,399 | -64.1% | 0.00% | – |
| Q2 2019 | $87,000 | -9.4% | 40,080 | +13.1% | 0.00% | -100.0% |
| Q1 2019 | $96,000 | -30.4% | 35,431 | +248.6% | 0.00% | 0.0% |
| Q4 2015 | $138,000 | +24.3% | 10,164 | -11.7% | 0.00% | 0.0% |
| Q3 2015 | $111,000 | -53.9% | 11,515 | -31.5% | 0.00% | 0.0% |
| Q2 2015 | $241,000 | +38.5% | 16,814 | -13.0% | 0.00% | 0.0% |
| Q1 2015 | $174,000 | +102.3% | 19,323 | +38.0% | 0.00% | 0.0% |
| Q4 2014 | $86,000 | -57.0% | 14,006 | -25.8% | 0.00% | 0.0% |
| Q3 2014 | $200,000 | +9900.0% | 18,876 | +18776.0% | 0.00% | – |
| Q3 2013 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2013 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |